Jiangsu Yahong Meditech 亚虹医药
6 significant filings since 29 May 2026: 2 on litigation, 2 on new listing and 2 on equity incentive. The latest, on 6 Aug 2026: 江苏亚虹医药科技股份有限公司关于仲裁进展暨提起仲裁反请求的公告.
自 29 May 2026 起有 6 份重大公告：litigation 2 份、new listing 2 份、equity incentive 2 份。最新一份（6 Aug 2026）：江苏亚虹医药科技股份有限公司关于仲裁进展暨提起仲裁反请求的公告。
Price History 价格走势
1 session 个交易日, Thu 24 Sep 2026 · Live one-minute prices · High 最高 ¥14.97 · Low 最低 ¥14.52 · +0.27% on the previous close of ¥14.69The tick on each bar marks the whole market, where 99.3% of rated reports in the same twelve months said Buy or Outperform. 刻度线为全市场水平：同期 99.3% 的评级为买入或跑赢。 Every rated report on this company said Buy or Outperform.
No broker has changed its rating on this company in the reports held.
| Broker 券商 | Analyst 分析师 | Latest Rating 最新评级 | Date 日期 | Reports 研报 | Target 目标价 |
|---|---|---|---|---|---|
| 太平洋 | 周豫,戎晓婕 | Buy 买入 | 18 Mar 2026 | 1 | 17.91 |
| 华鑫证券 | 胡博新,吴景欢 | Buy 买入 | 11 Mar 2026 | 2 | — |
| 西南证券 | 杜向阳,汤泰萌 | Unrated | 4 Nov 2025 | 1 | — |
Each row is a broker's latest report in the last twelve months. A price target is given in 1 of 4 reports. 每行为该券商近十二个月的最新研报；4 份中 1 份给出目标价。
Each bar counts the brokers publishing on this company in a quarter. The latest quarter is not yet complete. 每根柱为该季度发布本公司研报的券商数，最近一个季度尚未结束。